![](/img/cover-not-exists.png)
Dapagliflozin QD and exenatide QW dual therapy: a 24-week randomized, placebo-controlled, phase 2 study examining effects on bodyweight and prediabetes in obese nondiabetic adults
Lundkvist, Per, David Sjöström, C., Amini, Sam, Pereira, Maria J., Johnsson, Eva, Eriksson, Jan W.Language:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.12779
Date:
August, 2016
File:
PDF, 1.19 MB
english, 2016